Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03652441
Title Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cologne
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.